Nuveen Asset Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-169,674
| Closed | -$467K | – | 3487 |
|
|
2022
Q1 | $467K | Buy |
169,674
+59,286
| +54% | +$163K | ﹤0.01% | 3035 |
|
|
2021
Q4 | $511K | Sell |
110,388
-10,419
| -9% | -$48.2K | ﹤0.01% | 3069 |
|
|
2021
Q3 | $1.21M | Buy |
120,807
+4,043
| +3% | +$40.4K | ﹤0.01% | 2919 |
|
|
2021
Q2 | $1.92M | Sell |
116,764
-1,478
| -1% | -$24.3K | ﹤0.01% | 2736 |
|
|
2021
Q1 | $2.61M | Sell |
118,242
-19,590
| -14% | -$433K | ﹤0.01% | 2493 |
|
|
2020
Q4 | $4.26M | Buy |
137,832
+25,605
| +23% | +$792K | ﹤0.01% | 2155 |
|
|
2020
Q3 | $2.28M | Buy |
112,227
+31,843
| +40% | +$647K | ﹤0.01% | 2311 |
|
|
2020
Q2 | $1.24M | Buy |
80,384
+43,210
| +116% | +$664K | ﹤0.01% | 2532 |
|
|
2020
Q1 | $288K | Buy |
37,174
+123
| +0.3% | +$953 | ﹤0.01% | 2931 |
|
|
2019
Q4 | $530K | Buy |
37,051
+7,021
| +23% | +$100K | ﹤0.01% | 2894 |
|
|
2019
Q3 | $451K | Buy |
+30,030
| New | +$451K | ﹤0.01% | 2975 |
|